§ Mr. Bruce George
To ask the Secretary of State for Health (1) what studies are being undertaken to assess the efficacy and value of mepitel dressings for treating skin conditions; and when he expects to receive the results of studies; 
(2) if he will add mepitel dressings to the drug tariff to allow for prescribing in the community; 
(3) what assessments his Department has undertaken of the efficacy and value of mepitel dressings in treating patients with (i) epidermolysis bullosa and (ii) other skin conditions. 199W
§ Mr. Denham
Listings of appliances in Part IX of the Drug Tariff are made only in response to, and after consideration of, applications from the manufacturers. We regard all matters concerning such applications to be confidential unless the company chooses to reveal them. We would expect companies to provide any evidence needed to support their application.